Oncometabolite <scp>d</scp> -2HG alters T cell metabolism to impair CD8 <sup>+</sup> T cell function
Giulia Notarangelo(Harvard University), Marcia C. Haigis(Harvard University), Sandro Santagata(Harvard University), Mario L. Suvà(Broad Institute), Samuel K. McBrayer(The University of Texas Southwestern Medical Center), Alexandra J. Golby(Brigham and Women's Hospital), Kai W. Wucherpfennig(Dana-Farber Cancer Institute), Arlene H. Sharpe(Brigham and Women's Hospital), Shakchhi Joshi(Harvard University), Nathalie Y.R. Agar(Texas Endosurgery Institute), Peter Georgiev(Harvard University), Jia‐Ren Lin(Harvard University), Gerard Baquer(Center for Pain and the Brain), Alison E. Ringel(Ragon Institute of MGH, MIT and Harvard), Jefte M. Drijvers(Brigham and Women's Hospital), Sylwia A. Stopka(Brigham and Women's Hospital), Peter K. Sorger(Harvard University Press), Elma Zaganjor(Vanderbilt University), Jessica B. Spinelli(UMass Memorial Health Care), Elizabeth M. Perez(Broad Institute), Gregory J. Baker(University of California, Los Angeles), Kiran Kurmi(Harvard University), Ilaria Elia(Cell Technology (China)), Heide F. Baron(Harvard University)
Cited by 271
Related Papers
PD-1 and Its Ligands in Tolerance and Immunity
|Annual Review of Immunology|2008|5.3k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Copper induces cell death by targeting lipoylated TCA cycle proteins
|Science|2022|4.6k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|2.9k
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
|The Journal of Experimental Medicine|2009|2k